Comparison of the short-term efficacy of different Amplatzer models and similar occluders in the treatment of patent foramen ovale

ObjectiveTo compare the recent efficacy and safety of different Amplatzer models and similar occluder in the treatment of patent foramen ovale (PFO).MethodsPatients with PFO complicated with cryptogenic stroke or migraine who underwent transcatheter closure of PFO in the First Affiliated Hospital of...

Full description

Bibliographic Details
Main Authors: Yuxuan Lou, Yang Hua, Jing Shi, Fengze Yang, Yifei Wang, Yang Yang, Wei Sun, Xiangqing Kong, Hao Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-07-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2023.1092465/full
_version_ 1797783248687857664
author Yuxuan Lou
Yuxuan Lou
Yang Hua
Jing Shi
Fengze Yang
Yifei Wang
Yang Yang
Wei Sun
Xiangqing Kong
Xiangqing Kong
Hao Zhang
author_facet Yuxuan Lou
Yuxuan Lou
Yang Hua
Jing Shi
Fengze Yang
Yifei Wang
Yang Yang
Wei Sun
Xiangqing Kong
Xiangqing Kong
Hao Zhang
author_sort Yuxuan Lou
collection DOAJ
description ObjectiveTo compare the recent efficacy and safety of different Amplatzer models and similar occluder in the treatment of patent foramen ovale (PFO).MethodsPatients with PFO complicated with cryptogenic stroke or migraine who underwent transcatheter closure of PFO in the First Affiliated Hospital of Nanjing Medical University from September 2019 to March 2021 were selected. Patients were grouped according to the type of occluder device. The basic data of the patients were collected and followed up within 1 year after occlusion. Effectiveness was defined as no recurrence of stroke/remission of migraine symptoms and a negative postoperative foaming test, and safety events were counted as the combined results of serious adverse events.ResultsA total of 92 patients were selected, including 45 cases in the symmetrical group and 47 cases in the asymmetric group. There were no serious adverse events in the 2 groups during follow-up. 3 days and 1 month after occlusion, the number of shunt patients in the asymmetric group was significantly less than that in the symmetric group (χ2 = 5.484, P = 0.019; χ2 = 5.146, P = 0.023). The negative rate of blocked residual shunts in the asymmetric group was higher than that in the symmetric group at 1, 3, 6 and 12 months after occlusion (χ2 = 6.473, P = 0.011; χ2 = 4.305, P = 0.038; χ2 = 4.842, P = 0.027; χ2 = 4.034, P = 0.045). Headache in migraine patients in the asymmetric group was significantly better than headache in patients in the symmetric group (P = 0.038; P = 0.049).ConclusionAsymmetric Amplatzer and similar occluders provide greater efficacy in short-term occlusion than symmetric ones.
first_indexed 2024-03-13T00:23:22Z
format Article
id doaj.art-8edf55019ef94787856bd8cb8e084da5
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-03-13T00:23:22Z
publishDate 2023-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-8edf55019ef94787856bd8cb8e084da52023-07-11T11:35:03ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2023-07-011010.3389/fcvm.2023.10924651092465Comparison of the short-term efficacy of different Amplatzer models and similar occluders in the treatment of patent foramen ovaleYuxuan Lou0Yuxuan Lou1Yang Hua2Jing Shi3Fengze Yang4Yifei Wang5Yang Yang6Wei Sun7Xiangqing Kong8Xiangqing Kong9Hao Zhang10Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, ChinaSoutheast University School of Medicine, Nanjing, ChinaDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, ChinaDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, ChinaDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, ChinaDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, ChinaDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, ChinaDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, ChinaDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, ChinaSoutheast University School of Medicine, Nanjing, ChinaDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, ChinaObjectiveTo compare the recent efficacy and safety of different Amplatzer models and similar occluder in the treatment of patent foramen ovale (PFO).MethodsPatients with PFO complicated with cryptogenic stroke or migraine who underwent transcatheter closure of PFO in the First Affiliated Hospital of Nanjing Medical University from September 2019 to March 2021 were selected. Patients were grouped according to the type of occluder device. The basic data of the patients were collected and followed up within 1 year after occlusion. Effectiveness was defined as no recurrence of stroke/remission of migraine symptoms and a negative postoperative foaming test, and safety events were counted as the combined results of serious adverse events.ResultsA total of 92 patients were selected, including 45 cases in the symmetrical group and 47 cases in the asymmetric group. There were no serious adverse events in the 2 groups during follow-up. 3 days and 1 month after occlusion, the number of shunt patients in the asymmetric group was significantly less than that in the symmetric group (χ2 = 5.484, P = 0.019; χ2 = 5.146, P = 0.023). The negative rate of blocked residual shunts in the asymmetric group was higher than that in the symmetric group at 1, 3, 6 and 12 months after occlusion (χ2 = 6.473, P = 0.011; χ2 = 4.305, P = 0.038; χ2 = 4.842, P = 0.027; χ2 = 4.034, P = 0.045). Headache in migraine patients in the asymmetric group was significantly better than headache in patients in the symmetric group (P = 0.038; P = 0.049).ConclusionAsymmetric Amplatzer and similar occluders provide greater efficacy in short-term occlusion than symmetric ones.https://www.frontiersin.org/articles/10.3389/fcvm.2023.1092465/fullpatent foramen ovalecryptogenic strokemigraineclosureAmplatzer occluder
spellingShingle Yuxuan Lou
Yuxuan Lou
Yang Hua
Jing Shi
Fengze Yang
Yifei Wang
Yang Yang
Wei Sun
Xiangqing Kong
Xiangqing Kong
Hao Zhang
Comparison of the short-term efficacy of different Amplatzer models and similar occluders in the treatment of patent foramen ovale
Frontiers in Cardiovascular Medicine
patent foramen ovale
cryptogenic stroke
migraine
closure
Amplatzer occluder
title Comparison of the short-term efficacy of different Amplatzer models and similar occluders in the treatment of patent foramen ovale
title_full Comparison of the short-term efficacy of different Amplatzer models and similar occluders in the treatment of patent foramen ovale
title_fullStr Comparison of the short-term efficacy of different Amplatzer models and similar occluders in the treatment of patent foramen ovale
title_full_unstemmed Comparison of the short-term efficacy of different Amplatzer models and similar occluders in the treatment of patent foramen ovale
title_short Comparison of the short-term efficacy of different Amplatzer models and similar occluders in the treatment of patent foramen ovale
title_sort comparison of the short term efficacy of different amplatzer models and similar occluders in the treatment of patent foramen ovale
topic patent foramen ovale
cryptogenic stroke
migraine
closure
Amplatzer occluder
url https://www.frontiersin.org/articles/10.3389/fcvm.2023.1092465/full
work_keys_str_mv AT yuxuanlou comparisonoftheshorttermefficacyofdifferentamplatzermodelsandsimilaroccludersinthetreatmentofpatentforamenovale
AT yuxuanlou comparisonoftheshorttermefficacyofdifferentamplatzermodelsandsimilaroccludersinthetreatmentofpatentforamenovale
AT yanghua comparisonoftheshorttermefficacyofdifferentamplatzermodelsandsimilaroccludersinthetreatmentofpatentforamenovale
AT jingshi comparisonoftheshorttermefficacyofdifferentamplatzermodelsandsimilaroccludersinthetreatmentofpatentforamenovale
AT fengzeyang comparisonoftheshorttermefficacyofdifferentamplatzermodelsandsimilaroccludersinthetreatmentofpatentforamenovale
AT yifeiwang comparisonoftheshorttermefficacyofdifferentamplatzermodelsandsimilaroccludersinthetreatmentofpatentforamenovale
AT yangyang comparisonoftheshorttermefficacyofdifferentamplatzermodelsandsimilaroccludersinthetreatmentofpatentforamenovale
AT weisun comparisonoftheshorttermefficacyofdifferentamplatzermodelsandsimilaroccludersinthetreatmentofpatentforamenovale
AT xiangqingkong comparisonoftheshorttermefficacyofdifferentamplatzermodelsandsimilaroccludersinthetreatmentofpatentforamenovale
AT xiangqingkong comparisonoftheshorttermefficacyofdifferentamplatzermodelsandsimilaroccludersinthetreatmentofpatentforamenovale
AT haozhang comparisonoftheshorttermefficacyofdifferentamplatzermodelsandsimilaroccludersinthetreatmentofpatentforamenovale